End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.49 CNY | +0.56% |
|
+6.75% | +27.58% |
07-12 | Shyndec Pharma Unit Gets Rights for Ceftazidime Avibactam Sodium for Injection | MT |
07-09 | Shanghai Shyndec Pharmaceutical Obtains Drug Registration for Anti-Tumor Injection; Shares Jump 9% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.58% | 2.31B | |
+34.09% | 10.31B | |
+40.84% | 5.23B | |
-18.53% | 4.62B | |
+12.65% | 3.52B | |
-39.96% | 1.78B | |
-45.87% | 1.69B | |
-0.50% | 1.64B | |
0.00% | 1.59B | |
-33.28% | 1.36B |
- Stock Market
- Equities
- 600420 Stock
- News Shanghai Shyndec Pharmaceutical Co., Ltd.
- Shanghai Shyndec Pharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from a group of investors